Delivery Order SPE2DB24D9238-SPE2DB25FDQYF
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on August 14, 2025. The delivery order, which must be completed by September 5, 2025, covers the supply of VABYSMO 6 mg/0.05 ml syringes (0.05 ml units), an injectable pharmaceutical product. This award was issued without a set-aside designation, allowing the vendor to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 28, 2025, for Vabysmo 6 mg/0.05 ml syringes. The contract is valued at $5,966.88 under a firm fixed-price arrangement with an ultimate completion date of September 19, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's competitive positioning as a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,983.44 by the Defense Logistics Agency (DLA) on June 2, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes (0.05 mL) with an ultimate completion date of June 24, 2025. This delivery order was issued without a set-aside designation and represents a single-line procurement of this pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 ml syringes, a prescription medication used in ophthalmic treatment. The order has an ultimate completion date of September 26, 2025, and carries no set-aside designation. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $5,966.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml syringes. This firm fixed-price delivery order is scheduled for completion by July 22, 2025, and was awarded on June 30, 2025, without a set-aside designation. The contract does not utilize a specific small business or socioeconomic set-aside, indicating the vendor...
- This is a $6,224.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, with a period of performance through November 7, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a $8,950.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VABYSMO 6 mg/0.05 ml syringes. The contract was awarded on July 29, 2025, with an ultimate completion date of August 19, 2025, and carries no set-aside designation. DMS Pharmaceutical Group will perform the delivery order from its Park Ridge facility. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,933.76 on July 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. The award carries an ultimate completion date of August 8, 2025, and represents a specific delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,780.55 contract is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQYFDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,966.88 by the Defense Logistics Agency on August 6, 2025, for the supply of Vabysmo 6 mg/0.05 ml syringes. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its woman-owned small business status. This delivery order falls within DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain. The company holds a significant single-award IDC with the DLA valued at $499,999,999 through November 2026, which enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide. Vabysmo, a prescription pharmaceutical product, aligns with the company's portfolio of specialty medications and biologics regularly distributed to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/6/25 |